Argireline
Argireline. Topical hexapeptide marketed as a 'Botox-like' expression-line softener.
How it works. Competes with SNAP-25 at the SNARE complex, modestly reducing neurotransmitter release at the neuromuscular junction in the skin.
What the research supports. 2 graded claims. Strongest: Non-invasive alternative to neuromodulators (preclinical).
Hormonal impact. Effects on Acetylcholine release (local).
Side effects and interactions. 0 medication interactions listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Daily sunscreen and retinoid. Avoid combining with Open wounds or active dermatitis on the application site.
Common forms. Available as Topical cream and serum.
Community. Experiences from people who have tried Argireline. Anecdotes are not medical advice.
Argireline. Topical hexapeptide marketed as a 'Botox-like' expression-line softener.
What it is
Argireline is a SNAP-25-derived hexapeptide formulated into topical cosmetics for fine lines from repeated facial expression.
Also called
How it works
Competes with SNAP-25 at the SNARE complex, modestly reducing neurotransmitter release at the neuromuscular junction in the skin.
Pathways
- SNARE complex inhibition
- Acetylcholine release reduction at neuromuscular junction
Effects
- ↓Depth of expression lines with consistent use decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Hormonal impact
Side effects & interactions
Common side effects
- Mild local irritation
No notable medication interactions listed.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Daily sunscreen and retinoidAddresses static-aging contributors that Argireline does not.
Avoid combining
- Open wounds or active dermatitis on the application siteIncreased irritation and absorption.
Common forms
- Topical cream and serum
Discussion
Loading discussion…